NYU Langone Financial Reports

NYU Langone Health continues to achieve exceptional outcomes in quality and safety, driving sustained growth and strong operational performance. For the 12 months ended August 31, 2025, the organization reported an operating margin of 3.1 percent, with operating revenues more than $15.4 billion, marking a 9.6 percent increase compared to the previous year. This performance reflects the contributions from NYU Langone Hospitals, which achieved an operating margin of 7.5 percent, offset by the operating loss from the two medical schools.

Key factors in the enterprise’s growth include increases in patient volume, highlighted by a 5.0 percent rise in inpatient discharges, a 10.8 percent growth in outpatient surgical volume, and a 3.4 percent increase in emergency department visits. Streamlined care practices, including consistently low length of stay, have enhanced patient capacity while supporting higher patient acuity—a combination that positively influenced operating revenue growth. Maintaining operational efficiency, high quality, and patient safety remains a cornerstone of our financial strategy, reflecting our ongoing commitment to disciplined fiscal management and sustainable success.

2025 Fiscal Year

Annual Report
Dates: August 31, 2024, to August 31, 2025
Released: November 17, 2025

2024 Fiscal Year

Annual Report
Dates: August 31, 2023, to August 31, 2024
Released: November 18, 2024